Image Credit: Scientific Frontline / AI generated
Scientific Frontline: Extended "At a Glance" Summary: Gut Microbiome and Mild Cognitive Impairment Prediction
The Core Concept: A diagnostic approach utilizing machine learning to analyze the composition of gut bacteria and chemical metabolites in fecal samples to identify individuals with mild cognitive impairment and predict their rate of memory and cognitive decline.
Key Distinction/Mechanism: Rather than relying solely on cognitive testing or brain imaging, this method analyzes the combined profile of both gut bacteria (microbiome) and the chemicals they produce (metabolites) as an early, non-invasive biomarker for neurological changes.
Major Frameworks/Components:
- Diagnostic Markers (Mild Cognitive Impairment): Elevated levels of Izemoplasmatales spp. and the chemical proline; decreased levels of Ruminococcus spp., Lachnospira spp., and fumaric acid.
- Prognostic Markers (Faster Decline): Higher initial levels of Bilophila spp., arginine, aspartic acid, and hypoxanthine; lower levels of Coprococcus spp. strongly linked to faster cognitive decline over a one-year follow-up.
- Analytical Method: Application of machine learning algorithms to distinguish between healthy individuals and those with cognitive impairment with high accuracy.
Branch of Science: Microbiology; Neurology; Bioinformatics; Biochemistry
Future Application: The development of simple, non-invasive fecal tests to support earlier clinical diagnosis of mild cognitive impairment and pinpoint patients at risk for rapid progression to dementia, allowing for earlier intervention.
Why It Matters: Mild cognitive impairment affects approximately 25% of older adults globally, yet clinicians currently lack simple prognostic tools to determine whose condition will rapidly deteriorate; establishing the gut-brain link offers a critical new window into early-stage neurological decline.
New research has found that gut bacteria and chemicals could be used to identify people with mild cognitive impairment and help predict how quickly their memory and thinking might decline.
In what is thought to be the first study of its kind, researchers from Cardiff University and Imperial College London examined both gut bacteria and chemicals. Their findings could support earlier diagnosis and help spot people at risk of faster decline.
The researchers analyzed fecal samples from 35 older adults, most of them couples living together where one partner had mild cognitive impairment and the other did not, and used machine learning to see whether the samples could help diagnose the condition and predict how quickly it progresses.
The study found that people with mild cognitive impairment had a different mix of gut bacteria compared to people without cognitive impairment. In particular, people with mild cognitive impairment displayed significantly elevated levels of the bacteria Izemoplasmatales spp. and the gut chemical proline. They also showed decreased levels of Ruminococcus spp. and Lachnospira spp. bacteria, and lower levels of the chemical fumaric acid.
These bacteria belong to a larger group that has been linked to brain health in previous studies.
The team also tested for these bacterial markers in an independent group of people from a previous study, where they could still distinguish people with mild cognitive impairment from healthy individuals.
The researchers followed people with mild cognitive impairment for a year. They found that those whose initial samples had higher levels of the bacteria Bilophila spp. and the chemicals arginine, aspartic acid, and hypoxanthine, and lower levels of Coprococcus spp., showed a faster decline in memory and thinking skills.
Study co-author Dr. You Zhou, Cardiff University, said, “Mild cognitive impairment affects around one in four older adults worldwide, but we have no simple way of telling who will go on to decline quickly.”
“We found that a combination of gut bacteria and chemicals could distinguish people with mild cognitive impairment from healthy individuals with high accuracy, and certain gut chemicals were strongly linked to faster decline over the following year.”
“This was a small study and the findings need confirming in larger groups, but they point toward simple, non-invasive tests that could one day support earlier diagnosis.”
Co-author Professor Julian Marchesi, Imperial College London, said, “Gut bacteria and chemicals are increasingly recognized as an important link between the gut and the brain. By looking at both together, we get a much fuller picture of what’s changing in people with mild cognitive impairment. Future studies on larger groups of patients will help pinpoint exactly which microbes and chemicals matter most.”
The researchers say further studies are now needed in more diverse groups and to examine the influence of diet, lifestyle, ethnicity, environment, and genetic risk.
Reference material: What Is: Human Microbiome
Funding: The study was funded by the Rosetrees Trust. The researchers thank the participants and the Memory Team at Cardiff and Vale University Health Board.
Published in journal: MedComm
Authors: Birong Zhang, Richard Brown, Antony Bayer, Joanna Waring, B. Paul Morgan, Julian R. Marchesi, and You Zhou
Source/Credit: Cardiff University
Edited by: Scientific Frontline
Reference Number: mcb101926_01